Skip to main content

Table 1 Characteristics of the studied women (n = 110)

From: Inflammatory markers and cardiovascular risks among overweight-obese Emirati women

Demographics and medical history [number (percentage) of patients]

 Age, mean ± SD, years

39 ± 9 (median 36, range 30–65)

 Education

  Primary

28 (25)

  Secondary

38 (35)

  University

44 (40)

 Marital status

  Married

81 (74)

  Single

18 (16)

  Divorced

11 (10)

 Occupation

  Housewife

72 (65)

  Employed

22 (20)

  History of dyslipidemia

8 (7)

  History of diabetes

7 (6)

  Polycystic ovary syndrome

9 (8)

  Self-physical activity ≥150 min/week

16 (15)

Anthropometrics, mean ± SD (median and range)

 Waist circumference (cm)

100 ± 13 (median 99, range 71–144)

 Hip circumference (cm)

116 ± 11 (median 116, range 49–148)

 Waist: hip ratio

0.86 ± 0.08 (median 0.86, range 0.63–1.11)

 Body mass index (kg/m2)

34 ± 6 (median 33, range 25–58)

 Weight (kg)

84 ± 14 (median 83, range 58–123)

 Systolic blood pressure (mmHg)

120 ± 13 (median 120, range 92–158)

 Diastolic blood pressure (mmHg)

73 ± 9 (median 73, range 53–100)

 Percent body fat

41 ± 5 (median 41, range 29–54)

 Percent fat-free muscle

47 ± 5 (median 46, range 36–64)

Laboratory biomarkers, mean ± SD (median and range)

 Fasting blood glucose (mmol/L)

5.5 ± 1.8 (median 5.1, range 3.9–19.4)

 Hemoglobin A1c (%)

5.8 ± 0.9 (median 5.7, range 4.5–12.0)

 Total cholesterol (mmol/L)

4.9 ± 0.9 (median 4.9, range 3.4–7.7)

 LDL cholesterol (mmol/L)

3.0 ± 0.7 (median 3.0, range 1.4–5.4)

 HDL cholesterol (mmol/L)

1.1 ± 0.3 (median 1.0, range 0.5–2.6)

 Triglyceride (mmol/L)

1.0 ± 0.4 (median 1.0, range 0.4–2.3)

 Adiponectin (µg/L)

6.5 ± 3.4 (median 5.4, range 1.1–18.4)

 hsCRP (mg/L)

7.8 ± 7.7 (median 5.4, range 0.2–51.3)

 IL-6 (pg/mL)

2.7 ± 2.1 (median 2.0, range 0.2–14.0)

 TNF-α (ng/L)

0.014 ± 0.04 (median 0.013, range 0.007–0.037)

 25-Hydroxyvitamin D (nmol/L)

21.6 ± 15.1 (median 17.0, range 5.0–91.0)

  1. LDL low-density lipoprotein, HDL high-density lipoprotein, hsCRP high sensitivity C-reactive protein, IL-6 interleukin-6, TNF-α tumor necrosis factor-alpha